Large-scale testing (Phase 3)Study completedNCT00002109
What this trial is testing
Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy
Who this might be right for
HIV Infections
Immunobiology Research Institute